Question | ACAD Message Board Posts


ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  19594 of 19609  at  8/5/2022 2:16:57 PM  by

SuperM


 In response to msg 19593 by  SuperM
view thread

Question

The question that I keep asking in my mind repeatedly..........
 
If the FDA concluded that there are limitations in the interpretability of the phase 2 results, why on earth would they agree to a breakthrough designation and a dementia-related psychosis indication???
 
So Alzheimer's data is no good, we the FDA think you should go after dementia-related psychosis and approve of this trial design!
 
People, the FDA IS A JOKE! 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 8  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...